78 related articles for article (PubMed ID: 223417)
1. Biochemical characterization of the human lymphokine leukocyte migration inhibitory factor (LIF): role of cGMP as a specific inhibitor of the LIF esterase activity.
Bendtzen K
Adv Exp Med Biol; 1979; 114():485-90. PubMed ID: 223417
[No Abstract] [Full Text] [Related]
2. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
Bendtzen K
Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of the human lymphokine leucocyte migration-inhibitory factor (LIF): radioenzymic assay and inhibition by cGMP.
Bendtzen K
Scand J Immunol; 1979; 10(1):61-7. PubMed ID: 224450
[TBL] [Abstract][Full Text] [Related]
4. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
Bendtzen K
J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
[TBL] [Abstract][Full Text] [Related]
6. Increased polymorphonuclear leukocyte cGMP levels induced by the human lympholine, leukocyte migration inhibitory factor (LIF).
Bendtzen K; Klysner R
Immunopharmacology; 1979 Jul; 1(4):323-30. PubMed ID: 233586
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMP.
Bendtzen K
Biochim Biophys Acta; 1979 Jan; 566(1):183-91. PubMed ID: 215234
[TBL] [Abstract][Full Text] [Related]
8. Use of benzoyl-L-phenylalanyl-L-valyl-L-arginine (3H) methyl ester as a sensitive and selective substrate for the human lymphokine, leukocyte migration inhibitory factor (LIF).
Bendtzen K; Rocklin RE
J Immunol; 1980 Oct; 125(4):1775-81. PubMed ID: 6251137
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine effect upon the erythrocyte antibody uptake by human monocytes.
Sipka S; Kávai M; Teichmann F; Boldogh I; Szegedi G
Haematologia (Budap); 1987; 20(2):73-8. PubMed ID: 3115874
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
Bendtzen K
Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
[TBL] [Abstract][Full Text] [Related]
12. Human leucocyte migration inhibitory factor (LIF). V. Specific regulation of the lymphokine serine protease activity by 3',5'-cGMP and, possibly, 2',3'-cCMP.
Bendtzen K
Scand J Immunol; 1978; 8(1):53-61. PubMed ID: 212822
[TBL] [Abstract][Full Text] [Related]
13. Effects of esterase inhibitors and buthionine sulfoximine on the prevention of acetaminophen hepatotoxicity by N-acetylcysteine.
Wong BK; Corcoran GB
Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):397-408. PubMed ID: 3107095
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
Bendtzen K
Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte inhibitory factor (LIF): a lymphocyte mediator with esteratic properties.
Rocklin R
Fed Proc; 1978 Nov; 37(13):2743-7. PubMed ID: 710595
[TBL] [Abstract][Full Text] [Related]
16. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
Bendtzen K
Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
[TBL] [Abstract][Full Text] [Related]
17. [Leukocyte migration inhibitory factor (LIF). From biological test to biochemical characterization of this lymphokine].
Bendtzen K
Ugeskr Laeger; 1979 Feb; 141(6):377-80. PubMed ID: 217135
[No Abstract] [Full Text] [Related]
18. Partial characterization of a lymphoid cell line (Reh) product with leukocyte inhibitory factor (LIF) activity.
Rocklin RE; Blidy A; Butler J; Minowada J
J Immunol; 1981 Aug; 127(2):534-9. PubMed ID: 7019325
[No Abstract] [Full Text] [Related]
19. Evidence that human leukocyte inhibitory factor (LIF) is an esterase.
Rocklin RE; Rosenthal AS
J Immunol; 1977 Jul; 119(1):249-52. PubMed ID: 326958
[No Abstract] [Full Text] [Related]
20. Mechanism of differential inhibition of hepatic and pancreatic fatty acid ethyl ester synthase by inhibitors of serine-esterases: in vitro and cell culture studies.
Kaphalia BS; Mericle KA; Ansari GA
Toxicol Appl Pharmacol; 2004 Oct; 200(1):7-15. PubMed ID: 15451303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
